Andreas Reiter
About
Andreas Reiter is a scholar working on Rheumatology, Hematology and Genetics.
According to data from OpenAlex, Andreas Reiter has authored 278 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Rheumatology, 130 papers in Hematology and 122 papers in Genetics. Recurrent topics in Andreas Reiter's work include Eosinophilic Disorders and Syndromes (135 papers), Chronic Myeloid Leukemia Treatments (102 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (94 papers). Andreas Reiter is often cited by papers focused on Eosinophilic Disorders and Syndromes (135 papers), Chronic Myeloid Leukemia Treatments (102 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (94 papers). Andreas Reiter collaborates with scholars based in Germany, United Kingdom and United States. Andreas Reiter's co-authors include Nicholas C.P. Cross, Andreas Hochhaus, Georgia Metzgeroth, Andrew Chase, Jason Gotlib, Rüdiger Hehlmann, Amy V. Jones, Katerina Zoi, Francis Grand and Thomas Ernst and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Genetics.
In The Last Decade
Andreas Reiter
258 papers receiving 8.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Andreas Reiter Germany | 52 | 4.0k | 3.4k | 3.2k | 2.8k | 1.6k | 278 | 8.8k | ||
| Dan Jones United States | 51 | 4.6k 1.2× | 4.0k 1.2× | 2.3k 0.7× | 1.7k 0.6× | 1.1k 0.6× | 256 | 8.6k | ||
| Rajyalakshmi Luthra United States | 65 | 4.1k 1.0× | 3.6k 1.1× | 1.1k 0.3× | 5.0k 1.8× | 826 0.5× | 308 | 13.7k | ||
| Claudia Haferlach Germany | 53 | 6.9k 1.7× | 4.3k 1.3× | 892 0.3× | 3.5k 1.3× | 1.1k 0.6× | 449 | 9.7k | ||
| Anna Porwit Sweden | 34 | 4.4k 1.1× | 2.6k 0.8× | 529 0.2× | 2.2k 0.8× | 877 0.5× | 173 | 7.3k | ||
| David Dingli United States | 64 | 8.0k 2.0× | 2.7k 0.8× | 811 0.3× | 8.9k 3.2× | 970 0.6× | 465 | 14.8k | ||
| Gert J. Ossenkoppele Netherlands | 53 | 8.6k 2.2× | 2.8k 0.8× | 670 0.2× | 4.4k 1.6× | 1.9k 1.2× | 279 | 12.3k | ||
| Suzanne Kamel‐Reid Canada | 55 | 2.7k 0.7× | 1.7k 0.5× | 605 0.2× | 4.4k 1.6× | 928 0.6× | 285 | 12.1k | ||
| Joseph D. Khoury United States | 45 | 2.1k 0.5× | 1.6k 0.5× | 426 0.1× | 1.7k 0.6× | 945 0.6× | 327 | 6.9k | ||
| Eric D. Hsi United States | 62 | 2.1k 0.5× | 3.5k 1.0× | 632 0.2× | 3.2k 1.2× | 2.6k 1.6× | 405 | 12.2k | ||
| Frits van Rhee United States | 63 | 9.9k 2.5× | 2.0k 0.6× | 851 0.3× | 6.6k 2.4× | 2.1k 1.3× | 421 | 14.0k |
Countries citing papers authored by Andreas Reiter
Since
Specialization
Citations
This map shows the geographic impact of Andreas Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Reiter more than expected).
Fields of papers citing papers by Andreas Reiter
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Andreas Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Reiter. The network helps show where Andreas Reiter may publish in the future.
Co-authorship network of co-authors of Andreas Reiter
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Reiter. A scholar is included among the top collaborators of Andreas Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Reiter. Andreas Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tapper, William, Joannah Score, Andrew Chase, et al.. (2025). Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22 / CD40. Blood. 146(26). 3228–3233.
2.
Reiter, Andreas, Jason Gotlib, Iván Álvarez‐Twöse, et al.. (2025). Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control study. Leukemia Research. 157. 107919–107919.
3.
Kvasnicka, H. M., et al.. (2024). Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5. Medizinische Genetik. 36(1). 31–38.
4.
Vannucchi, Alessandro M., Jay Patel, William Shomali, et al.. (2024). MPN-384 A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients With Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 (FGFR1) Gene Rearrangement. Clinical Lymphoma Myeloma & Leukemia. 24. S430–S431.
5.
Stegelmann, Frank, Lino L. Teichmann, Florian H. Heidel, et al.. (2023). Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN). Leukemia. 37(4). 924–928.
6.
Metzgeroth, Georgia, Nicole Naumann, Johannes Lübke, et al.. (2023). Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. Leukemia. 37(9). 1860–1867.
7.
Lübke, Johannes, Nicole Naumann, Sebastian Kreil, et al.. (2022). Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis. Scientific Reports. 12(1). 14228–14228.
8.
Naumann, Nicole, Johannes Lübke, William Shomali, et al.. (2021). Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto‐oncogene, receptor tyrosine kinase (KIT) D816V mutations. British Journal of Haematology. 194(2). 344–354.
9.
Schwaab, Juliana, Knut Brockow, Philipp Riffel, et al.. (2021). Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosis. Annals of Allergy Asthma & Immunology. 128(3). 314–318.
10.
Gotlib, Jason, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, et al.. (2021). A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1). Blood. 138(Supplement 1). 385–385.
11.
George, Tracy I., Karen Moser, Andreas Reiter, et al.. (2021). Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis: Hematologic and Bone Marrow Responses from the Phase 2 Open-Label, Single-Arm, Pathfinder Study. Blood. 138(Supplement 1). 2565–2565.
12.
Stegelmann, Frank, Martin Grießhammer, Markus Bangerter, et al.. (2017). COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110). Haematologica. 102. 280–280.
13.
Reiter, Andreas, et al.. (2014). Factors influencing the adoption of and business case for Cloud computing in the public sector. Research Repository (Delft University of Technology). 1–10.
14.
Erben, Philipp, Juliana Schwaab, Georgia Metzgeroth, et al.. (2013). The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis. Annals of Hematology. 93(1). 81–88.
15.
Schnittger, Susanne, Ulrike Bacher, Tamara Alpermann, et al.. (2012). Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases. Haematologica. 97(12). 1890–1894.
16.
Reddy, Mamatha M., Nicole J. Croteau, Christoph Walz, et al.. (2010). Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism. Journal of Biological Chemistry. 285(42). 32596–32605.
17.
Chase, Andrew, Thomas Ernst, Andreas Fiebig, et al.. (2009). TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals. Haematologica. 95(1). 20–26.
18.
Berger, Ute, Ole Maywald, Markus Pfirrmann, et al.. (2005). Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. Leukemia. 19(6). 984–989.
19.
Reiter, Andreas. (2004). Differential photoneutron cross sections of light nuclei for neutron dosimetry. OpenGrey (Institut de l'Information Scientifique et Technique).
20.
Kreuder, Joachim, et al.. (2001). Effloreszenzen und Blutbildveränderungen bei einem 9 Monate alten Säugling mit Glutarazidurie Typ I. Klinische Pädiatrie. 213(2). 74–75.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dan Jones Breakdown of academic impact, for papers by Rajyalakshmi Luthra Breakdown of academic impact, for papers by Claudia Haferlach Breakdown of academic impact, for papers by Anna Porwit Breakdown of academic impact, for papers by David Dingli Breakdown of academic impact, for papers by Gert J. Ossenkoppele Breakdown of academic impact, for papers by Suzanne Kamel‐Reid Breakdown of academic impact, for papers by Joseph D. Khoury Breakdown of academic impact, for papers by Eric D. Hsi Breakdown of academic impact, for papers by Frits van Rhee